{"id":7976,"date":"2023-06-09T14:14:04","date_gmt":"2023-06-09T12:14:04","guid":{"rendered":"https:\/\/www.igmm.cnrs.fr\/?p=7976"},"modified":"2023-06-09T14:52:42","modified_gmt":"2023-06-09T12:52:42","slug":"prise-en-charge-du-test-sanguin-metaglut1-pour-diagnostiquer-la-maladie-de-de-vivo","status":"publish","type":"post","link":"https:\/\/www.igmm.cnrs.fr\/en\/prise-en-charge-du-test-sanguin-metaglut1-pour-diagnostiquer-la-maladie-de-de-vivo\/","title":{"rendered":"TAKING CHARGE OF THE METAglut1 BLOOD TEST FOR THE DIAGNOSIS OF DE VIVO DISEASE"},"content":{"rendered":"<p style=\"text-align: justify;\">The collaboration between several teams from <a href=\"https:\/\/www.aphp.fr\/\" target=\"_blank\" rel=\"noopener\">AP-HP<\/a>, l\u2019<a href=\"https:\/\/www.igmm.cnrs.fr\/?lang=fr\" target=\"_blank\" rel=\"noopener\">IGMM Institut de G\u00e9n\u00e9tique Mol\u00e9culaire de Montpellier<\/a> (<a href=\"https:\/\/www.cnrs.fr\/fr\" target=\"_blank\" rel=\"noopener\">CNRS<\/a>\/<a href=\"https:\/\/www.umontpellier.fr\/\" target=\"_blank\" rel=\"noopener\">Universit\u00e9 de Montpellier<\/a>) and <a href=\"https:\/\/www.metafora-biosystems.com\/\" target=\"_blank\" rel=\"noopener\">Metafora-Biosystems<\/a> is a success: for the first time, a diagnostic test, METAglut1, has received a positive decision from <a href=\"https:\/\/www.has-sante.fr\/jcms\/p_3432203\/fr\/forfait-innovation-le-dispositif-porte-ses-fruits\">Haute Autorit\u00e9 de Sant\u00e9<\/a> permitting the reimbursement of its costs by health insurance companies.<\/p>\n<p style=\"text-align: justify;\"><strong>METAglut1, a fast, reliable blood test, provides an early diagnosis of Glut1 deficiency syndrome, or De Vivo disease, a rare and disabling neurological condition.<\/strong><\/p>\n<p style=\"text-align: justify;\"><a style=\"letter-spacing: 0px;\" href=\"https:\/\/www.has-sante.fr\/jcms\/p_3432203\/fr\/forfait-innovation-le-dispositif-porte-ses-fruits\">Haute Autorit\u00e9 de Sant\u00e9 &#8211; Forfait innovation : le dispositif porte ses fruits (has-sante.fr)<\/a><\/p>\n<p><a href=\"https:\/\/n.neurology.org\/content\/100\/23\/e2360\" target=\"_blank\" rel=\"noopener\"><strong>https:\/\/n.neurology.org\/content\/100\/23\/e2360<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/finance.yahoo.com\/news\/metafora-test-early-diagnosis-vivo-130000663.html\" target=\"_blank\" rel=\"noopener\"><strong>https:\/\/finance.yahoo.com\/news\/metafora-test-early-diagnosis-vivo-130000663.html<\/strong><\/a><\/p>\n<p><strong><a href=\"https:\/\/www.cnrs.fr\/fr\/un-simple-test-sanguin-permet-desormais-de-diagnostiquer-la-maladie-de-de-vivo\">https:\/\/www.cnrs.fr\/fr\/un-simple-test-sanguin-permet-desormais-de-diagnostiquer-la-maladie-de-de-vivo<\/a><\/strong><\/p>\n<p><a href=\"https:\/\/www.aphp.fr\/contenu\/un-simple-test-sanguin-permet-desormais-de-diagnostiquer-la-maladie-de-de-vivo\" target=\"_blank\" rel=\"noopener\"><strong>https:\/\/www.aphp.fr\/contenu\/un-simple-test-sanguin-permet-desormais-de-diagnostiquer-la-maladie-de-de-vivo<\/strong><\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The collaboration between several teams from AP-HP, l\u2019IGMM Institut de G\u00e9n\u00e9tique Mol\u00e9culaire de Montpellier (CNRS\/Universit\u00e9 de Montpellier) and Metafora-Biosystems is a success: for the first time, a diagnostic test, METAglut1, has received a positive decision from Haute Autorit\u00e9 de Sant\u00e9 permitting the reimbursement of its costs by health insurance companies. METAglut1, a fast, reliable blood test, provides an early diagnosis &hellip; <a href=\"https:\/\/www.igmm.cnrs.fr\/en\/prise-en-charge-du-test-sanguin-metaglut1-pour-diagnostiquer-la-maladie-de-de-vivo\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">TAKING CHARGE OF THE METAglut1 BLOOD TEST FOR THE DIAGNOSIS OF DE VIVO DISEASE<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":7977,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,16],"tags":[],"class_list":["post-7976","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-news","category-science-en"],"_links":{"self":[{"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/posts\/7976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/comments?post=7976"}],"version-history":[{"count":4,"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/posts\/7976\/revisions"}],"predecessor-version":[{"id":7987,"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/posts\/7976\/revisions\/7987"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/media\/7977"}],"wp:attachment":[{"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/media?parent=7976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/categories?post=7976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.igmm.cnrs.fr\/en\/wp-json\/wp\/v2\/tags?post=7976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}